# Efficacy and Safety of T-817MA in Patients With Mild to Moderate Alzheimer's Disease

> **NCT00663936** · PHASE2 · COMPLETED · sponsor: **FUJIFILM Toyama Chemical Co., Ltd.** · enrollment: 373 (actual)

## Conditions studied

- Alzheimer's Disease

## Interventions

- **DRUG:** T-817MA
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00663936
- **Lead sponsor:** FUJIFILM Toyama Chemical Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-04
- **Primary completion:** 2011-05
- **Final completion:** 2011-06
- **Target enrollment:** 373 (ACTUAL)
- **Last updated:** 2013-11-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00663936

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00663936, "Efficacy and Safety of T-817MA in Patients With Mild to Moderate Alzheimer's Disease". Retrieved via AI Analytics 2026-07-02 from https://api.ai-analytics.org/clinical/NCT00663936. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*